Global Research Alliance to develop affordable vaccines in developing countries
About Global Research Alliance to develop affordable vaccines in developing countries :
First of its kind Global Research and Development joint venture between Merck and Co. and Wellcome Trust to develop affordable vaccines in certain areas to prevent diseases which typically affect people from low income countries.
Pairing two of the world's preeminent healthcare institutions, provides an opportunity to integrate the best of both to drive the investment and expertise required to develop and deliver vaccines to low income countries. The heart of the concept lies in creating a sustainable research organization, that operates like a business, but with a not for profit operating model.